Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
Alcon Inc. Ordinary Shares · Now $65.70
+2.3% in 3d after detection
Post-detection moves
1h
—
1d
+1.5%
3d
+2.3%
7d
+0.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS